Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study

Peer review reports

Original Submission
13 Jan 2023	Submitted	Original manuscript
29 Jan 2023	Reviewed	Reviewer Report
12 May 2023	Reviewed	Reviewer Report
23 May 2023	Author responded	Author comments - Amaury Daste
Resubmission - Version 2
23 May 2023	Submitted	Manuscript version 2
25 May 2023	Author responded	Author comments - Amaury Daste
Resubmission - Version 3
25 May 2023	Submitted	Manuscript version 3
3 Jun 2023	Reviewed	Reviewer Report
21 Jun 2023	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
29 Jun 2023	Editorially accepted
14 Jul 2023	Article published	10.1186/s12885-023-11133-5

Back to article page